SAN FRANCISCO & DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the transmission of a live satellite feed of a clinical case using the Tryton stent to an audience of several hundred interventional cardiologists at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2011 Conference in San Francisco.
